1. Home
  2. ACU vs IPHA Comparison

ACU vs IPHA Comparison

Compare ACU & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acme United Corporation.

ACU

Acme United Corporation.

HOLD

Current Price

$37.07

Market Cap

145.9M

ML Signal

HOLD

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$1.89

Market Cap

174.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACU
IPHA
Founded
1867
1999
Country
United States
France
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
145.9M
174.2M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
ACU
IPHA
Price
$37.07
$1.89
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.00
AVG Volume (30 Days)
9.2K
564.8K
Earning Date
10-21-2025
09-17-2025
Dividend Yield
1.73%
N/A
EPS Growth
N/A
N/A
EPS
2.45
N/A
Revenue
$194,960,991.00
$14,839,695.00
Revenue This Year
$3.05
$22.29
Revenue Next Year
$4.20
$43.90
P/E Ratio
$15.12
N/A
Revenue Growth
2.35
N/A
52 Week Low
$34.35
$1.43
52 Week High
$45.25
$3.51

Technical Indicators

Market Signals
Indicator
ACU
IPHA
Relative Strength Index (RSI) 47.72 50.64
Support Level $36.24 $1.85
Resistance Level $38.16 $2.01
Average True Range (ATR) 0.85 0.08
MACD 0.21 0.01
Stochastic Oscillator 59.02 69.64

Price Performance

Historical Comparison
ACU
IPHA

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

Share on Social Networks: